Stryker (SYK) EBIT Margin (2009 - 2026)
Stryker's (SYK) quarterly EBIT Margin came in at 25.18% in Q2 2026, up 670.0% year-over-year from 3.27% in Q2 2025, and up 61.94% quarter-over-quarter from 15.55% in Q1 2026.
Analysis
Stryker (SYK) EBIT Margin (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported EBIT Margin for 18 consecutive years, with 25.18% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBIT Margin rose 670.0% year-over-year to 25.18% in Q2 2026; TTM through Jun 2026 was 21.42%, a 624.0% increase from a year earlier, with the FY2025 full-year figure at 19.47%, up 314.0% from the prior year.
- EBIT Margin was 25.18% for Q2 2026 at Stryker, up from 15.55% in the prior quarter.
- Over five years, EBIT Margin peaked at 25.18% in Q2 2026 and troughed at 9.03% in Q4 2024.
- A 5-year average of 17.82% and a median of 18.51% in 2024 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin tumbled 1259 bps in 2024 and jumped 1613 bps in 2025, its largest moves.
- Over 5 years, EBIT Margin stood at 15.65% in 2022, then jumped by 38 bps to 21.62% in 2023, then tumbled by 58 bps to 9.03% in 2024, then surged by 179 bps to 25.16% in 2025, then climbed by 0 bps to 25.18% in 2026.
- The last three EBIT Margin figures came in at 25.18% (Q2 2026), 15.55% (Q1 2026), and 25.16% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.79 Bn | 179.19 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 124.38 Bn | 119.16 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 118.45 Bn | 109.63 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.32 Bn | 101.84 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.71 Bn | 66.17 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.56 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.03 Bn | 32.58 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.18% |
| Mar 31, 2026 | 15.55% |
| Dec 31, 2025 | 25.16% |
| Sep 30, 2025 | 18.74% |
| Jun 30, 2025 | 18.48% |
| Mar 31, 2025 | 14.27% |
| Dec 31, 2024 | 9.03% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 18.54% |
| Dec 31, 2023 | 21.62% |
| Sep 30, 2023 | 18.97% |
| Jun 30, 2023 | 19.32% |
| Mar 31, 2023 | 15.38% |
| Dec 31, 2022 | 15.65% |
| Sep 30, 2022 | 18.04% |
| Jun 30, 2022 | 17.18% |
| Mar 31, 2022 | 10.46% |
| Dec 31, 2021 | 17.42% |
| Sep 30, 2021 | 13.80% |